Canada: Federal Court Clarifies Duty Of Candour Owed During Prosecution Of Patent Applications

Last Updated: November 30 2009
Article by Steven Mason, Anita Nador and Steven Tanner

Most Read Contributor in Canada, September 2018

In a recent Federal Court decision of Lundbeck Canada Inc. v. Ratiopharm Inc., 2009 FC 1102 dated November 23, 2009, Justice Mactavish clarified the duty of candour owed by an applicant pursuant to s. 73(1)(a) of the Patent Act. As summarized by the court, s. 73(1)(a) provides that "an application for a patent shall be deemed to be abandoned if, amongst other things, the applicant does not reply in good faith to any requisition made by an examiner in connection with an examination." [emphasis added]

The court has examined the good faith duty in a number of prior decisions, most recently with regard to the duty to respond to a request by the patent examiner under s. 29 of the Patent Rules regarding the provision of prior art cited in corresponding patent applications or those that describe the same invention. In those cases, the court has taken a hard-line approach, stating that a lack of response to such a request results in automatic abandonment of the application.

In the present case, the court stated that in addition to having a duty to provide the relevant prior art to the patent office in light of such a requisition, the applicant, in replying to a rejection of anticipation or obviousness, must be careful not to mislead the Examiner of the interpretation of prior art. The facts of this particular case are as follows.

Canadian Patent Application No. 2,426,492 was filed in Canada on May 8, 2003 on behalf of its owner, H. Lundbeck A/S ("Lundbeck"). In an office action dated November 12, 2003, the patent examiner stated that the claims were obvious, contrary to s. 28.3 of the Patent Act. The claims were directed to the "synergistic use" of a combination of two previously known compounds in the treatment of mild cognitive impairment or dementia, such as Alzheimer's disease. The examiner's rejection noted that the claims were a mere aggregation of the prior compounds and that such claims to a combination of two compounds were invalid unless there was a new and unexpected result. The examiner further stated that there was "no evidence" of a synergistic effect.

In addition to the obviousness rejection, the examiner requested that the applicant provide "an identification of any prior art cited in respect of the United States and European Patent Office application." Although there was no corresponding patent application in either jurisdiction, the applicant identified two documents cited in an International Search Report. One of them was an article by Gary L. Wenk et al ("Wenk").

In response to the office action, Lundbeck stated that there are numerous articles that warn against and teach away from the combination of the two compounds that were the subject of the claims. Therefore, they argued, the combination would have been "counter-intuitive."

The Wenk article, previously provided to the examiner, suggested that the warnings against combining the compounds was limited to a subset of the class of compounds. Lundbeck did not specifically refer to the Wenk article in its response to the obviousness rejection in the office action, and neither did the examiner. The '492 Patent subsequently issued and listed on the Health Canada Patent Register pursuant to the Patented Medicines (Notice of Compliance) Regulations (the "PM(NOC) Regulations"). The Lundbeck case arose from an application launched by Lundbeck pursuant to the PM(NOC) Regulations to prevent the Minister of Health from issuing a NOC (i.e., granting market approval) to Ratiopharm until the expiry of the patent. At the hearing, Ratiopharm argued that the '492 Patent Application was deemed to be abandoned because the applicant had breached its duty of good faith in failing to alert the examiner to the importance of the Wenk article.

Justice Mactavish held that not only did the applicant owe a duty of candour pursuant to s. 73(1)(a) of the current Patent Act, but that the duty had been breached. Justice Mactavish cited with approval Justice Hughes' analogy in G.D. Searle & Co. v. Novopharm Ltd., 2007 FC 81 between patent examination and ex parte motions before the court. On the ultimate question of the scope of the duty, Justice MacTavish held as follows:

The duty of good faith imposed by paragraph 73(1)(a) of the post-1996 Patent Act requires that this prior art be fully and fairly described by applicants and their agents when answering requisitions from the Patent Office.

Interestingly, although the court found that the Wenk article did not anticipate the claims of the '492 Patent or render them obvious, since it said "nothing" about the synergistic effect of combining the compounds, the '492 Patent Application was deemed to be abandoned since the applicant had failed to specifically cite or discuss the Wenk article in response to the examiner's obviousness rejection. Justice Mactavish held that it was the one study that was directly relevant to the office action. The fact that Wenk was previously disclosed to the examiner was not an answer to the applicant's statements that the prior art "clearly" taught away from combining the compounds. In light of the teachings of Wenk, Justice Mactavish held that this statement was not a fair representation of the prior art. So despite her finding that the claims were not anticipated, nor obvious in light of the Wenk reference, the patent application was deemed abandoned for lack of a good faith reply.

Accordingly, Lundbeck's application for a prohibition Order in respect of the '492 Patent was dismissed.

This decision puts into question the prior understanding of the law that there is no positive duty by the applicant to provide relevant references to the patent office, absent a specific requisition by the examiner. This decision appears to impose a duty on the applicant to present ─ and accurately discuss ─ the relevance of the most pertinent prior art it is aware of, and to ensure that any statements on the record accurately reflect its contents and do not mislead. One can not necessarily rely on simply placing the prior art on the record for the examiner to review and consider.

To read the full decision, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions